DEVELOPMENT

DEVELOPMENT

TissueGen is advancing toward clinical development a pipeline of novel, extended release

TissueGen is advancing toward clinical development a pipeline of novel, extended release

formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases.

formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases.

A paradigm shift in drug delivery systems

TissueGen's proprietary technology makes possible extended release formulations for drugs ranging from small molecules to temperature-sensitive biologics. Our patent-protected technology is particularly well suited to creating a new class of drug-eluting devices designed to orchestrate the body's own healing processes to significantly improve clinical outcomes after trauma or surgery.

ABOUT

biologics. Our patent-protected technology is particularly well suited to creating a new class

release formulations for drugs ranging from small molecules to temperature-sensitive

TissueGen's proprietary technology makes possible extended

of drug-eluting devices designed to orchestrate the body's own healing processes

to significantly improve clinical outcomes after trauma or surgery.

“The potential applications for TissueGen technology in advanced drug delivery, nerve regeneration, and tissue engineering are truly exciting. “

- Dr. Kevin Nelson, Founder and CSO

APPLICATIONS

A

D

V

A

N

C

E

D

TissueGen Nerve Regeneration

R

E

G

E

N

E

R

O

I

T

A

N

TissueGen Tissue Engineering

E

N

G

I

N

E

E

G

N

I

R

/ 0 3

/ 0 3

/ 0 3